Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach

Area of Science:

• Immunology
• Virology
• Bioinformatics

Background:

• HIV-1 genomic variability across global isolates presents a significant challenge for developing a universally effective HIV vaccine.
• Targeting conserved regions of the virus is crucial for a broadly applicable vaccine strategy.

Purpose of the Study:

• To identify broadly conserved HIV-1 cytotoxic T cell (CTL) epitopes that are present across diverse viral strains.
• To utilize bioinformatics tools for screening large HIV sequence databases and predicting potential epitopes.

Main Methods:

• Employed the Conservatrix algorithm to screen the Los Alamos National Laboratory HIV sequence database for conserved protein sequences.
• Utilized the EpiMatrix tool to predict putative HIV-1 CTL epitopes from the screened sequences.
• Synthesized 100 peptides representing conserved HLA ligands and tested their binding to HLA molecules on T2 cells.
• Assessed T cell responses to synthesized peptides using ELIspot assays with peripheral blood mononuclear cells (PBMCs) from HIV-1 infected individuals.

Main Results:

• Of 75 tested peptides, 57 (76%) demonstrated binding to corresponding MHC molecules on T2 cells.
• 43 out of 100 peptides (43%) stimulated gamma-interferon release in ELIspot assays, indicating T cell recognition.
• Identified 31 novel, highly conserved HIV-1 epitopes with potential for broad recognition.
• Nine novel epitopes were confirmed to be restricted by multiple HLA alleles, including some recognized by MHC 'supertypes' and promiscuous epitopes.

Conclusions:

• The identified epitopes are conserved across a wide spectrum of HIV-1 sequences from diverse geographical regions, including Latin America, Africa, Asia, Europe, and the US.
• This bioinformatics-driven approach successfully identified cross-clade HIV-1 epitopes.
• The discovery of these conserved epitopes may significantly advance the development of a globally relevant HIV-1 vaccine.